Sign in Subscribe
Nanoparticles

Nickel/Manganese Nanoparticles Show Promise in Combatting Staphylococcus aureus Infections

Strategic Insights

— 1 min read

Researchers from Al-Iraqia University have published a study on the antibacterial efficacy of nickel/manganese nanoparticles against Staphylococcus aureus, a bacterium responsible for a variety of infections. The study used atomic force microscopy and absorption spectroscopy to analyze the nanoparticles, which were synthesized using a leaf extract from Lepidium sativum. The results showed that the nanoparticles exhibited significant antibacterial activity against S. aureus, with a minimum inhibitory concentration of 1-4 mg/ml.

Key Takeaways:

  • The nickel/manganese nanoparticles were created using a leaf extract from Lepidium sativum and were analyzed using atomic force microscopy and absorption spectroscopy.
  • The nanoparticles were found to be spherical in shape and solid, with an average size of 45.9 nm.
  • The nanoparticles exhibited significant antibacterial activity against S. aureus, with a minimum inhibitory concentration of 1-4 mg/ml.
  • The nanoparticles were able to inhibit the growth of S. aureus biofilms, with 80% inhibition at 0.5 mg/ml and 100% inhibition at 1 mg/ml.
  • The study suggests that nickel/manganese nanoparticles may be a promising treatment option for S. aureus infections.

Statistics:

  • The average size of the nickel/manganese nanoparticles was 45.9 nm.
  • The minimum inhibitory concentration of the nanoparticles against S. aureus isolates was 1-4 mg/ml.
  • The nanoparticles exhibited 80% inhibition of S. aureus biofilms at 0.5 mg/ml and 100% inhibition at 1 mg/ml.
  • The study used atomic force microscopy and absorption spectroscopy to analyze the nanoparticles.

Sources:

  • Assessment of the antibacterial efficacy of nickel/manganese nanoparticles against staphylococcus aureus. BIO Web of Conferences, 2025,173():02022.
  • NewsRx. New Staphylococcus aureus Research from Al-Iraqia University Outlined (Assessment of the antibacterial efficacy of nickel/manganese nanoparticles against staphylococcus aureus). Life Science Weekly. June 10, 2025; p 3418.

Read more